Diamorphine
- Generic Name
- Diamorphine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H23NO5
- CAS Number
- 561-27-3
- Unique Ingredient Identifier
- 70D95007SX
- Background
Diamorphine (heroin) is a narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Internationally, diamorphine is controlled under Schedules I and IV of the Single Convention on Narcotic Drugs. As heroin, it is illegal to manufacture, possess, or sell in the United States and the UK. However, under the name diamorphine, heroin is a legal prescription drug in the United Kingdom.
- Indication
Diamorphine, as a prescription medication in the United Kingdom, is indicated for use in the treatment of severe pain associated with surgical procedures, myocardial infarction or pain in the terminally ill and for the relief of dyspnoea in acute pulmonary edema .
- Associated Conditions
- -
- Associated Therapies
- -
Phase II of Fargo Parks Sports Center Unveiled
Sandy Paws Rescue introduces dogs like Gru, Wendy, and Genny seeking homes. Studies on cannabis use show no significant cognitive changes. Minnesotans recall severe winters. Homelessness issues in Denver criticized. Hospitals often release homeless patients back to streets. Midway City Council passes fire service budget. Colorado children face online risks. Opioid crisis impacts Pima County.
From “Just Say No” to emerging therapies: How three different reform initiatives could shape drug regulation
The U.S. regulates drugs via the CSA and FDA, with Schedule I drugs like cannabis, psilocybin, and MDMA facing strict restrictions. Reform paths include state-led legalization for cannabis, private sector innovation for ketamine, and federal appeals for psychedelics. Insurance coverage for these drugs is complex, with potential changes as legal statuses evolve.
The Challenge's Robin Hibbard Debuts Healthy Look and Career After Drug Arrests
Robin Hibbard, former 'The Challenge' star, has transformed her life after drug arrests, showcasing a healthier look and new career. She's fighting for custody of her children and has filed for divorce. Despite past legal troubles, including drug possession and trespassing, Robin appears to be making positive changes.
Bacup man and serviceman jailed for roles in drug conspiracy
Oliver Harrison and Peter Downs jailed for roles in an organised crime group, involving drug trafficking and firearm transfer. Harrison, a former serviceman, acted as a courier, while Downs was higher up, dealing in cocaine and cannabis. Both pleaded guilty, with Downs sentenced to 13.5 years and Harrison to 8 years.
Drugs kingpin used secret phone network to flood streets of Staffordshire with kilos of heroin
Yusuf Ali, 30, used EncroChat to sell six kilos of heroin in Staffordshire and beyond, operating a commercial-scale drug network. Arrested in June last year, he pleaded guilty and was jailed for 12 years, highlighting his significant role in the drug supply chain.
Reported use of most drugs among adolescents remained stable or decreased post-COVID-19
Adolescent substance use has remained at lower levels for the fourth consecutive year post-COVID-19, with declines in alcohol, nicotine vaping, and cannabis use among certain grades. The Monitoring the Future Survey highlights stable or decreasing trends in drug use, emphasizing the need for continued research and intervention to sustain these positive trends.
Reported use of most drugs among adolescents remained stable with notable declines post-COVID-19
Adolescent substance use has remained at lowered levels for four years post-COVID-19, with declines in alcohol, nicotine vaping, and cannabis use. The Monitoring the Future Survey highlights stable trends and some decreases in 2024, marking unprecedented reductions in teenage substance use.
New Year Eve Drug Bust: Cachar Police Seizes 153gm Heroin from Jirighat
Cachar Police seized 153 grams of suspected heroin from Lalmonsom Vaiphei in Jirighat, concealed in 13 soap cases, marking progress in combating the drug menace near Manipur.
Coloradans will have a new psychiatric treatment option in psilocybin on Jan. 1
Ryan Chrapko transformed his life using psilocybin, moving from substance abuse to mental health improvement. Colorado's Proposition 122 now allows clinical psychedelic use, offering therapeutic benefits for conditions like PTSD and depression, with professional guidance enhancing outcomes.
Is Maine finally turning the tide on overdose deaths? Maybe.
Maine sees a 21% decrease in drug overdose deaths from Jan-Oct 2024 compared to 2023, with efforts like harm reduction, naloxone distribution, and outreach programs contributing. Despite progress, challenges remain, including stigma and the need for more treatment options. Experts caution against declaring victory, emphasizing the ongoing crisis.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath